PALO ALTO, Calif.--(BUSINESS WIRE)--Building upon its successful biotechnology portfolio, Hercules Technology Growth Capital, Inc. (NASDAQ: HTGC), a leading specialty finance company providing growth capital to venture capital and private equity backed technology and life science companies, today announced that on March 21, 2007 it provided $15 million of debt financing to Aegerion Pharmaceuticals, Inc., a New Jersey-based pharmaceutical company focused on the development and commercialization of therapeutics to treat cardiovascular and metabolic disease.
